Kura Oncology
The Director of Statistical Programming at Kura Oncology will provide technical leadership and programming support for clinical development projects, overseeing the creation, validation, and delivery of statistical programming deliverables from study start-up through regulatory submission and post‑marketing. The role involves collaboration with biostatisticians, data managers, CRO vendors, and cross‑functional teams to ensure high‑quality, compliant data packages and process improvements.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2014
Kura Oncology is a precision oncology biotechnology company focused on realizing the promise of targeted medicines to help patients with cancer lead better, longer lives. The company discovers and develops small-molecule therapies designed to inhibit specific cancer-driving pathways and genetic alterations, advancing programs through preclinical and clinical development. Kura works with clinical investigators and partners to test its candidates in genetically defined patient populations with the goal of delivering meaningful, durable treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Kura Oncology.
10% above the average for this role
Kura Oncology Inc. Q4 Loss Increases
1 week ago
Statistical Programming Contractor
CRISPR Therapeutics
Sr. Manager, Statistical Programming
Servier
Associate Director, Statistical Programming
Corcept Therapeutics
Statistical Programming Lead
Parexel
Senior Statistical (SAS) Programmer
Parexel
Statistical Programmer II (R Programming) - Poland (Home-based) - FSP
Parexel